SEC Form 4 · accession 0001562180-18-004315
ARRAY BIOPHARMA INC · ARRY
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Kyle Lefkoff
Director
Period of report
Oct 25, 2018
Accepted (ET)
Oct 29, 2018 · 6:10 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001100412
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Oct 26, 2018 | M | 5,000 | — | A | 22,720 | D | |
| Common StockF2 | holding | — | — | — | 45,000 | I | See footnote |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy)F3 | $14.55 | Oct 25, 2018 | A | 25,000 | A | — | Oct 25, 2028 | Common Stock | 25,000 | 25,000 | D |
| Restricted Stock UnitsF4 | $0.00 | Oct 25, 2018 | A | 5,000 | A | — | — | Common Stock | 5,000 | 5,000 | D |
| Restricted Stock UnitsF5 | $0.00 | Oct 26, 2018 | M | 5,000 | D | — | — | Common Stock | 5,000 | 0 | D |
Explanation of responses
- F1Shares issued upon settlement of Restricted Stock Units ("RSUs") granted by Array BioPharma Inc. ("Array") on October 26, 2017, as a result of the vesting of all such RSUs.
- F2Comprised of 30,000 shares of common stock in trust for the benefit of Mr. Lefkoff's minor children and 15,000 shares of common stock held by BV Partners III Profit Sharing account for the benefit of Mr. Lefkoff.
- F3The options vest in full on October 25, 2019, subject to continued service on Array's board of directors.
- F4RSUs awarded to the reporting person for no additional cash consideration and each represents a contingent right to receive one share of common stock. The RSUs vest in full and will be settled in common stock on October 25, 2019, subject to continued service on Array's board of directors.
- F5The RSUs vested and were settled in common stock on October 26, 2018.